Bids Are Invited For Acquisition Of Cancer And High Cost Medicines.

Acquisition Of Cancer And High Cost Medicines.. Zolydronic Acid, Human Albumin, Alphapordine, Alfaepoetin, Alphaepoetin, Alfaepoetin, Atozolizumab, Atozolizumab, Azacitidine, Bevacizumab, Bevacizumab, Beimmab, Beimmube, Bleomycin Sulfate, Bortezomibe, Kabazoxel, Carboplatin, Carboplatin, Carboximosis Ferrrica, Carfilzomib, Cemeiplimab, Cetuximab, Cetuximab, Cyclophosphamide, Cyclophosphamide, Cyclophosphamide, Cisplatin, Cisplatin, Citarabine, Quote Abina, Citarabine, Chlorambuccila, Crizotinib, Dabrafenib, Dacarbazine, Daratumumab, Daratumumab, Daratumumab, Docetaxel, Doxorubicine, Doxorubicin Hydrochloride, Doxorrubicin Hydrochloride, Dostarlimab, Dupilumab, Durvalumab, Eltrombopag Olamine, Ecoline Mesylato, Etoposite, Fluoruracil, Fluoruracil, Calcium Folic, Fosaprepipepiral, Fulvest, Gencitabine, Gencitabin Hydrochloride, Gencientabin Hydrochloride, Granisetrone, Hydroxyurea, Ibruutinib, Ifosphamide, Ifosphamide, Human Immunoglobulin, Infliximab, Ipilimmube, Irinotecan Hydrochloride, Irinotecan Hydrochloride, Lanreotide Acetate, Lenvatinib, Lenvatinib, Melfalana, Mesna, Mesna, Natalizumab, Nilotinib, Nintedanib, Nivolumab, Nivolumab, Obinutuzumab, Ocrelizumab, Octreotide, Olaparibe, Olaparibe, Omalizumab, Osimertinib, O Simertinibe, Oxaliplastin, Oxaliplastin, Paclitaxel, Paclitaxel, Panitumumab, Pembrolizumab, Pemetrexede, Pemetrexede, Trastuzumab, Pertuzumab, Ramucirumab, Ramucirumab, Regofenib, Rituximab, Rituximab